Derma Sciences Cmn (DSCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2015 | 03-2015 | 12-2014 | 09-2014 | 06-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,006 | 16,498 | 19,397 | 43,264 | 57,090 |
| Marketable Securities | 45,000 | 50,000 | 55,996 | 41,245 | 31,493 |
| Receivables | 9,144 | 8,210 | 8,758 | 7,490 | 7,861 |
| Inventories | 17,546 | 15,841 | 13,281 | 14,970 | 17,600 |
| Other current assets | 0 | 0 | 814 | 0 | 0 |
| TOTAL | $86,269 | $93,655 | $100,836 | $110,130 | $117,109 |
| Non-Current Assets | |||||
| PPE Net | 3,883 | 3,590 | 3,614 | 3,288 | 3,232 |
| Investments And Advances | 8,430 | 8,437 | 8,423 | 6,757 | 7,566 |
| Intangibles | 24,781 | 25,527 | 26,273 | 27,236 | 27,993 |
| Other Non-Current Assets | 141 | 140 | 144 | 145 | 147 |
| TOTAL | $37,235 | $37,695 | $38,454 | $37,427 | $38,937 |
| Total Assets | $123,504 | $131,350 | $139,291 | $147,557 | $156,047 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,283 | 6,214 | 3,676 | 5,882 | 4,625 |
| Accrued Expenses | 4,753 | 4,770 | 5,523 | 5,469 | 4,494 |
| TOTAL | $11,036 | $10,984 | $11,511 | $11,350 | $9,119 |
| Non-Current Liabilities | |||||
| Long Term Debt | 471 | 489 | N/A | N/A | 233 |
| Other Non-Current Liabilities | 0 | 0 | 521 | 216 | 0 |
| TOTAL | $2,260 | $2,183 | $2,215 | $1,797 | $1,969 |
| Total Liabilities | $13,296 | $13,167 | $13,726 | $13,147 | $11,088 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 25,807 | 25,728 | 25,701 | 25,248 | 25,248 |
| Common Shares | 258 | 257 | 253 | 253 | 252 |
| Retained earnings | -123,838 | -114,552 | -103,942 | -94,375 | -83,128 |
| Other shareholders' equity | 658 | 765 | 912 | 789 | 1,482 |
| TOTAL | $110,208 | $118,183 | $125,565 | $134,410 | $144,958 |
| Total Liabilities And Equity | $123,504 | $131,350 | $139,291 | $147,557 | $156,047 |